Latest Articles

In this interview, Dr. Yotam Ophir discusses the different types of narratives that exist around science, their impact and why retractions should be interpreted as a positive step in scientific progress.

This article highlights the adverse impact of microplastics (MPs) on our environment, detection methods for MPs and the challenges in the detection of MPs.

This article will explore how the move to digitize laboratory processes promises to make data integrity and compliance, an essential goal for regulated laboratories, an easier task.

What is supervised learning? Combined with big data, this machine learning technique has the power to change the world. In this article, we’ll explore the topic of supervised learning, but will first touch on some recent machine learning history.

The study of the universe through the field of cosmology has exploded but there are still surprises in store and much to be discovered. This article provides insight on work that will be taking advantage of the next generation of supercomputers.

Both pharmaceutical companies and regulators have collaborated closely over the course of the COVID-19 pandemic to develop vaccines, diagnostic tests and other therapies quicker than ever before and have shown us that clinical development can be accelerated. However, there are still several long-standing barriers to progress, when the focus isn’t on a global pandemic, that must now be remedied.

Over the last 18 months, the UK National Health Service (NHS) has been hit hard by the COVID-19 pandemic, with nearly 130,000 deaths from COVID-19 recorded. Could a more digitized, data-centric NHS have saved lives? A new study examining how patients were treated over the first wave of the pandemic has shown how machine learning-based methods could transform how standard NHS care is conducted.

What is dimensionality reduction, what are autoencoders and what does any of that have to do with good conversation?

The laboratory of Professor Hendrik Dietz in the Department of Physics explores the possibility of building molecular devices at the nanometer scale using different materials, including DNA. The group's latest research, published in Nature Materials, demonstrates their success in building icosahedral shells that can "trap" viral pathogens using DNA.

The European Proteomics Infrastructure Consortium providing Access, or EPIC-XS, started in January 2019. It brings together a consortium of world-leading, highly innovative European proteomics facilities with the shared goal of supporting excellent life sciences research in Europe. In this article, Martina O'Flaherty provides an overview of some of the successes of the consortium so far.